These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32813243)

  • 1. Reverse Docking for the Identification of Molecular Targets of Anticancer Compounds.
    Ruiz-Moreno AJ; Dömling A; Velasco-Velázquez MA
    Methods Mol Biol; 2021; 2174():31-43. PubMed ID: 32813243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing.
    Luo Q; Zhao L; Hu J; Jin H; Liu Z; Zhang L
    PLoS One; 2017; 12(2):e0171433. PubMed ID: 28196116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDock: A Suite for Molecular Inverse Docking and Target Prediction.
    Ma Z; Zou X
    Methods Mol Biol; 2021; 2266():313-322. PubMed ID: 33759135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives.
    Jung JC; Lee JH; Oh S; Lee JG; Park OS
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5527-31. PubMed ID: 15482917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Substituted-4-hydroxycoumarin as a new scaffold with potent CDK inhibition and promising anticancer effect: Synthesis, molecular modeling and QSAR studies.
    Abdel Latif NA; Batran RZ; Khedr MA; Abdalla MM
    Bioorg Chem; 2016 Aug; 67():116-29. PubMed ID: 27372186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives.
    Dimić DS; Kaluđerović GN; Avdović EH; Milenković DA; Živanović MN; Potočňák I; Samoľová E; Dimitrijević MS; Saso L; Marković ZS; Dimitrić Marković JM
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors.
    Tortorella P; Laghezza A; Durante M; Gomez-Monterrey I; Bertamino A; Campiglia P; Loiodice F; Daniele S; Martini C; Agamennone M
    J Chem Inf Model; 2016 Jun; 56(6):1216-27. PubMed ID: 27269808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2-acylated and sulfonated 4-hydroxycoumarins: In vitro urease inhibition and molecular docking studies.
    Rashid U; Rahim F; Taha M; Arshad M; Ullah H; Mahmood T; Ali M
    Bioorg Chem; 2016 Jun; 66():111-6. PubMed ID: 27140727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.
    Stanchev S; Momekov G; Jensen F; Manolov I
    Eur J Med Chem; 2008 Apr; 43(4):694-706. PubMed ID: 17614164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
    Scarpino A; Ferenczy GG; Keserű GM
    Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational allosteric ligand binding site identification on Ras proteins.
    McCarthy M; Prakash P; Gorfe AA
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):3-10. PubMed ID: 26487442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.
    Wang N; Wang L; Xie XQ
    J Chem Inf Model; 2017 Nov; 57(11):2686-2698. PubMed ID: 29016123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and in silico studies of the physicochemical properties of potential inhibitors for the phosphotransferase system of Streptococcus mutans.
    Rivera-Pérez WA; Yépes-Pérez AF; Martínez-Pabón MC
    Arch Oral Biol; 2019 Feb; 98():164-175. PubMed ID: 30500666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
    Kumar H; Raj U; Gupta S; Varadwaj PK
    J Biomol Struct Dyn; 2016 Oct; 34(10):2171-83. PubMed ID: 26479578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx.
    Bharatham N; Finch KE; Min J; Mayasundari A; Dyer MA; Guy RK; Bashford D
    J Mol Graph Model; 2017 Jun; 74():54-60. PubMed ID: 28351017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Akt kinase inhibitors through structure-based virtual screening and their evaluation as potential anticancer agents.
    Chuang CH; Cheng TC; Leu YL; Chuang KH; Tzou SC; Chen CS
    Int J Mol Sci; 2015 Feb; 16(2):3202-12. PubMed ID: 25648320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.